Vessel co-option in glioblastoma: emerging insights and opportunities

被引:0
|
作者
Giorgio Seano
Rakesh K. Jain
机构
[1] PSL Research University,Tumor Microenvironment Laboratory, Institut Curie Research Center, Paris Saclay University
[2] Inserm U1021,Edwin L. Steele Laboratory, Department of Radiation Oncology
[3] CNRS UMR3347,undefined
[4] Massachusetts General Hospital and Harvard Medical School,undefined
来源
Angiogenesis | 2020年 / 23卷
关键词
Vessel co-option; Glioblastoma; Anti-angiogenesis; Cell migration; Tumor microenvironment;
D O I
暂无
中图分类号
学科分类号
摘要
Vessel co-option is the movement of cancer cells towards and along the pre-existing vasculature and is an alternative to angiogenesis to gain access to nutrients. Vessel co-option has been shown as a strategy employed by some glioblastoma (GBM) cells to invade further into the brain, leading to one of the greatest challenges in treating GBM. In GBM, vessel co-option may be an intrinsic feature or an acquired mechanism of resistance to anti-angiogenic treatment. Here, we describe the histological features and the dynamics visualized through intravital microscopy of vessel co-option in GBM, as well as the molecular players discovered until now. We also highlight key unanswered questions, as answering these is critical to improve understanding of GBM progression and for developing more effective approaches for GBM treatment.
引用
收藏
页码:9 / 16
页数:7
相关论文
共 50 条
  • [1] Vessel co-option in glioblastoma: emerging insights and opportunities
    Seano, Giorgio
    Jain, Rakesh K.
    ANGIOGENESIS, 2020, 23 (01) : 9 - 16
  • [2] The Inhibition of Vessel Co-Option as an Emerging Strategy for Cancer Therapy
    Carrera-Aguado, Ivan
    Marcos-Zazo, Laura
    Carrancio-Salan, Patricia
    Guerra-Paes, Elena
    Sanchez-Juanes, Fernando
    Munoz-Felix, Jose M.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (02)
  • [3] Vessel co-option in cancer
    Kuczynski, Elizabeth A.
    Vermeulen, Peter B.
    Pezzella, Francesco
    Kerbel, Robert S.
    Reynolds, Andrew R.
    NATURE REVIEWS CLINICAL ONCOLOGY, 2019, 16 (08) : 469 - 493
  • [4] Vessel co-option in cancer
    Elizabeth A. Kuczynski
    Peter B. Vermeulen
    Francesco Pezzella
    Robert S. Kerbel
    Andrew R. Reynolds
    Nature Reviews Clinical Oncology, 2019, 16 : 469 - 493
  • [5] GLIOBLASTOMA VESSEL CO-OPTION AND TRANSITION TO A RESISTANT CELL STATE ARE INDUCED BY CHEMORADIATION
    Pichol-Thievend, C.
    Anezo, O.
    Pettiwala, A. M.
    Bourmeau, G.
    Montagne, R.
    Lyne, A.
    Guichet, P.
    Deshors, P.
    Ballestin, A.
    Blanchard, B.
    Reveilles, J.
    Ravi, V. M.
    Joseph, K.
    Heiland, D. H.
    Julien, B.
    Leboucher, S.
    Besse, L.
    Legoix, P.
    Dingli, F.
    Liva, S.
    Furumaya, C.
    Marcos, L. Kovandzic
    Masliantsev, K.
    Daubon, T.
    Schnell, O.
    Beck, J.
    Servant, N.
    Karayan-Tapon, L.
    Cavalli, F. M. G.
    Seano, G.
    NEURO-ONCOLOGY, 2023, 25
  • [6] Development of Tumor-Vasculature Interaction on Chip Mimicking Vessel Co-Option of Glioblastoma
    Jinseung Bae
    Min-Hyeok Kim
    Seokgyu Han
    Sungsu Park
    BioChip Journal, 2023, 17 : 77 - 84
  • [7] Development of Tumor-Vasculature Interaction on Chip Mimicking Vessel Co-Option of Glioblastoma
    Bae, Jinseung
    Kim, Min-Hyeok
    Han, Seokgyu
    Park, Sungsu
    BIOCHIP JOURNAL, 2023, 17 (01) : 77 - 84
  • [8] Tumor vessel co-option: The past & the future
    Cuypers, Anne
    Truong, Anh-Co Khanh
    Becker, Lisa M.
    Saavedra-Garcia, Paula
    Carmeliet, Peter
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [9] The emerging roles of circular RNAs in vessel co-option and vasculogenic mimicry: clinical insights for anti-angiogenic therapy in cancers
    Ying Shao
    Bingjian Lu
    Cancer and Metastasis Reviews, 2022, 41 : 173 - 191
  • [10] The emerging roles of circular RNAs in vessel co-option and vasculogenic mimicry: clinical insights for anti-angiogenic therapy in cancers
    Shao, Ying
    Lu, Bingjian
    CANCER AND METASTASIS REVIEWS, 2022, 41 (01) : 173 - 191